论文部分内容阅读
Objective: We aimed to evaluate the effectiveness and safety of intravenous (IV) plus intraperitoneal (IP) chemotherapy compared to IV chemotherapy alone for patients with gastric cancer.Methods: Electronic databases were searched up to June 2013.Two authors independently assessed the quality of included studies.The GRADE System was adopted to rate the level of evidence.